Literature DB >> 29289683

Perturbations in the p53/miR-34a/SIRT1 pathway in the R6/2 Huntington's disease model.

Regina Hertfelder Reynolds1, Maria Hvidberg Petersen1, Cecilie Wennemoes Willert1, Marie Heinrich1, Nynne Nymann1, Morten Dall2, Jonas T Treebak2, Maria Björkqvist3, Asli Silahtaroglu1, Lis Hasholt1, Anne Nørremølle4.   

Abstract

The three factors, p53, the microRNA-34 family and Sirtuin 1 (SIRT1), interact in a positive feedback loop involved in cell cycle progression, cellular senescence and apoptosis. Each factor in this triad has roles in metabolic regulation, maintenance of mitochondrial function, and regulation of brain-derived neurotrophic factor (BDNF). Thus, this regulatory network holds potential importance for the pathophysiology of Huntington's disease (HD), an inherited neurodegenerative disorder in which both mitochondrial dysfunction and impaired neurotrophic signalling are observed. We investigated expression of the three members of this regulatory triad in the R6/2 HD mouse model. Compared to wild-type littermates, we found decreased levels of miR-34a-5p, increased SIRT1 mRNA and protein levels, and increased levels of p53 protein in brain tissue from R6/2 mice. The upregulation of SIRT1 did not appear to lead to an increased activity of the enzyme, as based on measures of p53 acetylation. In other words, the observed changes did not reflect the known interactions between these factors, indicating a general perturbation of the p53, miR-34a and SIRT1 pathway in HD. This is the first study investigating the entire triad during disease progression in an HD model. Given the importance of these three factors alone and within the triad, our results indicate that outside factors are regulating - or dysregulating - this pathway in HD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Huntington's disease; SIRT1; miR-34a; p53

Mesh:

Substances:

Year:  2017        PMID: 29289683     DOI: 10.1016/j.mcn.2017.12.009

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  11 in total

Review 1.  Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

Authors:  Mario J Bertogliat; Kahlilia C Morris-Blanco; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2019-12-12       Impact factor: 3.921

2.  HIV-1 Tat-mediated microglial inflammation involves a novel miRNA-34a-NLRC5-NFκB signaling axis.

Authors:  Palsamy Periyasamy; Annadurai Thangaraj; Venkata Sunil Bendi; Shilpa Buch
Journal:  Brain Behav Immun       Date:  2019-03-11       Impact factor: 7.217

Review 3.  MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.

Authors:  T P Nhung Nguyen; Mandeep Kumar; Ernesto Fedele; Giambattista Bonanno; Tiziana Bonifacino
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

4.  Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington's Disease.

Authors:  Tripti Joshi; Vipendra Kumar; Elena V Kaznacheyeva; Nihar Ranjan Jana
Journal:  Mol Neurobiol       Date:  2021-04-26       Impact factor: 5.590

Review 5.  Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders.

Authors:  Islauddin Khan; Kumari Preeti; Valencia Fernandes; Dharmendra Kumar Khatri; Shashi Bala Singh
Journal:  Cell Mol Neurobiol       Date:  2021-05-01       Impact factor: 4.231

Review 6.  Brain SIRT1 Mediates Metabolic Homeostasis and Neuroprotection.

Authors:  Jing Xu; Charlie W Jackson; Nathalie Khoury; Iris Escobar; Miguel A Perez-Pinzon
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-23       Impact factor: 5.555

7.  Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington's Disease Monkey pluripotent stem cells.

Authors:  Alexandra V Goodnight; Isaac Kremsky; Sujittra Khampang; Yoon Hee Jung; James M Billingsley; Steven E Bosinger; Victor G Corces; Anthony W S Chan
Journal:  Epigenetics Chromatin       Date:  2019-11-13       Impact factor: 4.954

8.  AAV5-miHTT Lowers Huntingtin mRNA and Protein without Off-Target Effects in Patient-Derived Neuronal Cultures and Astrocytes.

Authors:  Sonay Keskin; Cynthia C Brouwers; Marina Sogorb-Gonzalez; Raygene Martier; Josse A Depla; Astrid Vallès; Sander J van Deventer; Pavlina Konstantinova; Melvin M Evers
Journal:  Mol Ther Methods Clin Dev       Date:  2019-10-04       Impact factor: 6.698

Review 9.  Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases.

Authors:  Yi-Ying Wu; Hung-Chih Kuo
Journal:  J Biomed Sci       Date:  2020-04-07       Impact factor: 8.410

10.  Cerebellar Predominant Increase in mRNA Expression Levels of Sirt1 and Sirt3 Isoforms in a Transgenic Mouse Model of Huntington's Disease.

Authors:  Andras Salamon; Rita Maszlag-Török; Gábor Veres; Fanni Annamária Boros; Evelin Vágvölgyi-Sümegi; Anett Somogyi; László Vécsei; Péter Klivényi; Dénes Zádori
Journal:  Neurochem Res       Date:  2020-06-10       Impact factor: 4.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.